Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer.

Autor: Cook DP; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada. david.cook@uottawa.ca.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada. david.cook@uottawa.ca., Galpin KJC; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Rodriguez GM; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Shakfa N; Queen's Cancer Research Institute, Kingston, ON, Canada., Wilson-Sanchez J; Queen's Cancer Research Institute, Kingston, ON, Canada., Echaibi M; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Pereira M; Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada., Matuszewska K; Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada., Haagsma J; The Mary & John Knight Translational Ovarian Cancer Research Unit, Lawson Health Research Institute, London, ON, Canada., Murshed H; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Cudmore AO; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., MacDonald E; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Tone A; Ovarian Cancer Canada, 145 Front St E #205, Toronto, ON, Canada., Shepherd TG; The Mary & John Knight Translational Ovarian Cancer Research Unit, Lawson Health Research Institute, London, ON, Canada., Petrik JJ; Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada., Koti M; Queen's Cancer Research Institute, Kingston, ON, Canada., Vanderhyden BC; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.

Publikováno v: Communications biology [Commun Biol] 2023 Nov 13; Vol. 6 (1), pp. 1152. Date of Electronic Publication: 2023 Nov 13.